Evidence map›Paper›PMID 35253069›Full record

ArticlePsychopharmacology2022

Role of 5-HT

Yasmim A Serra, Thaísa Barros-Santos, Alexia Anjos-Santos, Natali D Kisaki, Caio Jovita-Farias, João P C Leite, Maria C E Santana, João P S A Coimbra, Nailton M S de Jesus, Agnieszka Sulima and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Serotonin 5-HTFrontiers in neuroscience · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Therapeutic mechanisms of psychedelics and entactogens.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Yasmim A SerraDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil.
Thaísa Barros-SantosDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Alexia Anjos-SantosDrug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Natali D KisakiDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil.
Caio Jovita-FariasDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil.
João P C LeiteDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Maria C E SantanaDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
João P S A CoimbraDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Nailton M S de JesusDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Agnieszka SulimaDrug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Paulo C R BarbosaDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil.
Elena L A Malpezzi-MarinhoDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Kenner C RiceDrug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Alexandre J Oliveira-LimaDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil.
Laís F BerroDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil. lberro@umc.edu.ORCID http://orcid.org/0000-0003-4841-4117
Eduardo A V MarinhoDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Rod. Ilhéus/Itabuna, Km 16, Ilhéus, BA, 45662-0, Brazil. eavmarinho@uesc.br.
Universidade Estadual de Santa Cruz · BRNational Institute on Alcohol Abuse and Alcoholism · USUniversity of Mississippi Medical Center · US

Funding

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid ReceptorsZIADA000527 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2025
$23.2M
Intramural NIH HHS ZIA DA000527
6 · The paper itself

Abstract

rationaleAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT

objectivesThe aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT

methodsMale mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT

resultsTreatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.

conclusionsTreatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT

Indexed as

BanisteriopsisAlcohol DrinkingAnimalsEthanolMaleMiceN,N-DimethyltryptamineReceptor, Serotonin, 5-HT2ASerotoninEthanolN,N-DimethyltryptamineReceptor, Serotonin, 5-HT2ASerotonin5-HT2AAyahuascaEthanolMiceSelf-administrationSerotonin

Identifiers

PMID35253069
PMCPMC10750423
OpenAlexW4220804493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.